Discovering D&O: Life Sciences’ Biggest Risk
We know that life science companies buy Directors & Officers coverage. But for many who are just starting their companies or are still in the building phase, the why is not always clear. Life science is a risky business but we also know that it is an innovative and health-altering mission. So how do we keep your leaders safe from potential risk?
Join us and our fantastic Marsh McLennan Agency speaker Adam Kibble, Vice President of Management Liability, to walk through why protecting your directors and officers is not only a check box in your insurance program but a key part of life sciences business and learn more about the best practices around D&O coverage and how we are seeing D&O impact our life science clients.
What you will learn?
• Common risks impacting Life Science executives
• D&O insurance: What’s covered and what’s not
• D&O considerations (Drug discovery through NDA, Series A through IPO)